Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma

Figure 2

Tumor distribution on the basis of costimulatory molecule genes. (a) HCC patients could be classified as two clusters through employing consensus clustering (). (b) Kaplan-Meier survival for OS between two clusters. (c) Heat map of clinicopathological features and differentially costimulatory molecule gene expression levels between two clusters.

(a)

(b)

(c)